Claims for Patent: 12,064,438

Summary for Patent: 12,064,438

Title:	Pharmaceutical preparation excellent in light stability and dissolution property
Abstract:	The present invention provides a preparation that is minimally colored through irradiation with light by coating a preparation containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, or a crystal thereof with a light stabilizing substance and a polymer, particularly with one or more of titanium oxide and talc used as the light stabilizing substance and hypromellose used as the polymer.
Inventor(s):	Naomi HAYASHI, Masato Gomi, Shohei AIKAWA
Assignee:	Shionogi and Co Ltd
Application Number:	US16/764,067
Patent Claims:	1. A solid preparation comprising: a compound represented by the formula (I): or a pharmaceutically acceptable salt thereof, croscarmellose sodium, and a coating layer comprising at least one light-stabilizing substance and at least one polymer selected from the group consisting of hypromellose, polyvinyl alcohol and hydroxypropyl cellulose, wherein the solid preparation is in the form of a tablet, and the tablet is coated by the coating layer. 2. The solid preparation according to claim 1, wherein the light-stabilizing substance in the coating layer is at least one selected from the group consisting of edible tar dye, edible lake tar dye, edible natural dye, ferric oxide, titanium oxide and talc. 3. The solid preparation according to claim 1, wherein the light-stabilizing substance in the coating layer is at least one selected from the group consisting of Food Red No. 2, Food Red No. 3, Food Red No. 102, Food Red No. 104, Food Red No. 105, Food Red No. 106, Food Yellow No. 4, Food Yellow No. 5, Food Green No. 3, Food Blue No. 1, Food Blue No. 2, Food Red No. 3 aluminum lake, Food Yellow No. 4 aluminum lake, Food Yellow No. 5 aluminum lake, Food Blue No. 1 aluminum lake, Food Blue No. 2 aluminum lake, carmine, sodium copper chiorophyllin, copper chlorophyll, red oxide, red ferric oxide, yellow ferric oxide, black iron oxide, yellow oxide of iron, titanium oxide and talc. 4. The solid preparation according to claim 3, wherein the light-stabilizing substance in the coating layer is at least one selected from the group consisting of red ferric oxide, yellow ferric oxide, black iron oxide, yellow oxide of iron, titanium oxide and talc. 5. The solid preparation according to claim 4, wherein the light-stabilizing substance in the coating layer is at least one selected from the group consisting of titanium oxide and talc. 6. The solid preparation according to claim 1, wherein the polymer in the coating layer is at least one selected from the group consisting of hypromellose and hydroxypropyl cellulose. 7. The solid preparation according to claim 6, wherein the polymer is hypromellose. 8. The solid preparation according to claim 1, wherein the light stabilizing substance is at least one selected from the group consisting of titanium oxide and talc, and the polymer is hypromellose in the coating layer. 9. The solid preparation according to claim 1, wherein the color difference ΔE is not more than 13 at optical illumination of 1.2 million lux. 10. The solid preparation according to claim 1, which is packaged in an aluminum blister package. 11. The solid preparation according to claim 1, wherein a release rate of the compound represented by formula (I) is not less than 80% after 45 minutes of initiation of a dissolution test. 12. The solid preparation according to claim 1, which comprises an amount of the compound represented by formula (I) of 10 mg, 20 mg, 40 mg or 80 mg. 13. The solid preparation according to claim 1, comprising: the compound represented by formula (I) in an amount of 40 mg or 80 mg, the croscarmellose sodium in an amount of 1 to 10% by weight based on the total amount of the solid preparation, and a coating layer comprising titanium oxide, talc and the at least one polymer, wherein the solid preparation further comprises: a lubricant in an amount of 0.1 to 5 % by weight based on the total amount of the solid preparation, and a binder in an amount of 0.5 to 10% by weight based on the total amount of the solid preparation. 14. The solid preparation according to claim 1, comprising: the compound represented by formula (I) in an amount of 40 mg or 80 mg, the croscarmellose sodium in an amount of 1 to 10% by weight based on the total amount of the solid preparation, and a coating layer comprising titanium oxide, talc and hypromellose, wherein the solid preparation further comprises: sodium stearyl fumarate in an amount of 0.1 to 5% by weight based on the total amount of the solid preparation, and polyvinyl pyrrolidone in an amount of 0.5 to 10% by weight based on the total amount of the solid preparation.